Importance of beta cell mass for glycaemic control in people with type 1 diabetes.

Jansen, Theodorus J P; Brom, Maarten; Boss, Marti; Buitinga, Mijke; Tack, Cees J; van Meijel, Lian A; de Galan, Bastiaan E; Gotthardt, Martin

Jansen, Theodorus J P; Brom, Maarten; Boss, Marti; Buitinga, Mijke; Tack, Cees J; van Meijel, Lian A; de Galan, Bastiaan E; Gotthardt, Martin.

Jansen TJP; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands.
Brom M; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands.
Boss M; Department of Medical Imaging, Radboud University Medical Center, Nijmegen, the Netherlands. marti.boss@radboudumc.nl.
Buitinga M; Nutrition and Movement Sciences, Maastricht University, Maastricht, the Netherlands.
Tack CJ; Radiology and Nuclear Medicine, Maastricht UMC+, Maastricht, the Netherlands.
van Meijel LA; Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
de Galan BE; Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Gotthardt M; Internal Medicine, Maxima Medical Center, Veldhoven, the Netherlands.

Diabetologia ; 66(2): 367-375, 2023 02.

Article en En | MEDLINE | ID: mdl-36394644

Asunto(s)

Diabetes Mellitus Tipo 1; Humanos; Diabetes Mellitus Tipo 1/metabolismo; Péptido C/metabolismo; Control Glucémico; Páncreas/metabolismo; Glucemia/metabolismo; Glucosa/metabolismo

Palabras clave

Beta cell mass; Exendin; Glucose control; Glucose variability; Hypoglycaemic burden; PET imaging; Pancreatic beta cell; Type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article